Randomized phase III trial of dose-dense MVAC or GC as perioperative chemotherapy for muscle-invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathological responses

• C. Pfister,
• G. Gravis,
• A. Flechon,
• M. Soulie,
• L. Guy,
• B. Laguerre,
• N. Mottet,
• F. Joly,
• Y. Allory,
• V. Harter,
• S. Culine

Affiliations

C. Pfister

G. Gravis

A. Flechon

M. Soulie

L. Guy

B. Laguerre

N. Mottet

F. Joly

Y. Allory

V. Harter

S. Culine